36.5000.54% ( -0.200 )
Delay Closed: Nov 16, 16:08:11Overview
SUNSHINE PHARMA (6887)
Sunshine Lake Pharma Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases,...
- Open
- 36.180
- High
- 37.340
- Low
- 36.180
- Prev. Close
- 36.700
- Volume
- 214.53K
- Turnover
- 7.84M
- Avg Price
- 36.560
- Bid/Ask Ratio
- 95.01%
- Amplitude
- 3.16%
- 52wk High
- 50.550
- Volume Ratio
- 0.06
- Turnover Ratio
- 0.07%
- 52wk Low
- 15.010
- HK Mkt Cap
- 11.63B
- Market CapHKD
- 20.96B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.571
- EPSDynamic
- -2.42
- EPSStatic
- --
- BVPS
- 7.75
- P/B
- 4.71
- HK Shares
- 318.74M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 574.29M
- Min lot size
- 100
- Currency
- HKD
SUNSHINE PHARMA Analyst Rating
View moreForecast & Rating
May 19, 2025Price forecast
HK$14.00-61.65%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 0
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
Tip Ranks · Sunshine Lake Pharma’s Olorigliflozin Added to China’s 2026 Reimbursement List
Simplywall · Yushuai Zhang Bought 3.8% More Shares In Sunshine Lake Pharma
Market Movers · Sunshine Pharma drops 4% in Hong Kong trading
Global Report · Chongqing Machinery Sells an Auto Unit as Sunshine Lake Pivots to Insulin
Tip Ranks · Sunshine Lake Pharma Wins China Nod for Dual-Action Insulin, Expands Global Footprint
Global Report · For Hong Kong's Overlooked Names, 2026 Is an Access Story, Not an Earnings Story
